Status In progress
Technology type Medicine
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Further information Topic in appraisal.
Process STA Standard
ID number 6336

Provisional Schedule

Expected publication 25 September 2024

Project Team

Project lead Jeremy Powell

Email enquiries

Stakeholders

Companies sponsors AstraZeneca (olaparib)
Others Department of Health and Social Care
  NHS England
Patient carer groups Black Health Agency for Equality
  Breast Cancer Now
  Breast Cancer UK
  Cancer Black Care
  Cancer Equality
  Helen Rollason Cancer Charity
  Independent Cancer Patients Voice
  Macmillan Cancer Support
  Maggie’s Centres
  Marie Curie
  MET UP UK
  South Asian Health Foundation
  Specialised Healthcare Alliance
  Tenovus Cancer Care
Professional groups Association of Breast Surgery
  Association of Cancer Physicians
  British Geriatrics Society
  British Institute of Radiology
  British Psychosocial Oncology Society
  British Oncology Pharmacy Association
  British Society of Interventional Radiology
  Cancer Research UK
  Royal College of General Practitioners
  Royal College of Nursing
  Royal College of Pathologists
  Royal College of Physicians
  Royal College of Radiologists
  Royal Pharmaceutical Society
  Royal Society of Medicine
  Society and College of Radiographers
  UK Breast Cancer Group
  UK Clinical Pharmacy Association
  UK Oncology Nursing Society
Associated public health groups Public Health Wales
  UK Health Security Agency
Comparator companies Pfizer (talazoparib)
General commentators All Wales Therapeutics and Toxicology Centre
  Allied Health Professionals Federation
  Board of Community Health Councils in Wales
  British National Formulary
  Care Quality Commission
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
  Medicines and Healthcare products Regulatory Agency
  National Association of Primary Care
  National Pharmacy Association
  NHS Confederation
  Scottish Medicines Consortium
  Welsh Government
  Welsh Health Specialised Services Committee
Relevant research groups Against Breast Cancer
  Breast Cancer Hope
  Cochrane Breast Cancer Group
  Cochrane UK
  Genomics England
  Institute of Cancer Research
  MRC Clinical Trials Unit
  National Institute for Health Research
  Pro-Cancer Research Fund

Timeline

Key events during the development of the guidance:

Date Update
02 May 2024 Invitation to participate
08 April 2024 - 22 April 2024 Review proposal consultation
15 February 2024 In progress

For further information on how we select topics for development, please see our page about topic selection